Zuellig Pharma在韩国开设临床试验支持创新中心，以加速药物开发并提高亚太地区的临床试验效率。
The establishment of this innovation center in South Korea positions it as a key hub for clinical research in APAC. It will support the development of new medicines by providing cutting-edge infrastructure and services, thereby contributing to the region's growing biopharmaceutical ecosystem and accelerating the availability of novel treatments for patients.
New Clinical Trial Support Innovation Center launched in South Korea.
Aims to support domestic and global clinical research.
Enhances infrastructure for drug development in APAC.
This investment in South Korea enhances the region's capacity for advanced clinical research, supporting global pharmaceutical innovation and potentially leading to faster access to new therapies for APAC populations.
Aims to support domestic and global clinical research.
Enhances infrastructure for drug development in APAC.
登录后可保存信号笔记。
登录